#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Netherton's syndrome Ependymoma Infection in an immunocompromised host Malignant central nervous system neoplasm Stress cardiomyopathy Heavy menstrual bleeding Gastrooesophageal cancer Deafness neurosensory Advanced systemic mastocytosis Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Metachromatic leukodystrophy Vaginal cancer Leukocyte adhesion deficiency type I Retinal artery occlusion Gastrointestinal disorder More trials…

    Learn about Rare Diseases

    Familial haemophagocytic lymphohistiocytosis – Treatment Mantle cell lymphoma – Treatment Nephrotic syndrome – Diagnostics Factor VIII deficiency – Life with Disease Andersen-Tawil syndrome Erdheim-Chester disease – Diagnostics Malignant fibrous histiocytoma – Trials in Disease Combined immunodeficiency Sarcoma – Life with Disease Langerhans’ cell histiocytosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cobamamide Teverelix Folinic Acid Sodium Hyaluronate Canakinumab Glenzocimab Retinol Palmitate Nido-361 Kan-101 Insulin Lispro RIMIDUCID Asciminib Hydrochloride Losartan Potassium Gimeracil Polydextrose BGB-16673 Sonidegib Landiolol Hydrochloride Fianlimab Macrogol 3350 More therapies…

    Learn about Your Condition

    Ewing's sarcoma metastatic Dementia with Lewy bodies Pneumothorax Neuropathy peripheral Angina pectoris Candida infection Lichen planus Bronchiolitis Systemic sclerosis pulmonary Post-acute COVID-19 syndrome Mixed-type liposarcoma Adenomyosis Postpartum haemorrhage Enteritis Schizoaffective disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A Study of Trastuzumab Deruxtecan Treatment for Patients with Early-Stage HER2-Positive or HER2-Low Breast Cancer Who Show Signs of Molecular Relapse

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    • HER2 positive breast cancer
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    Germany

  • Evaluation of Cemiplimab Safety and Effectiveness as First Treatment for Advanced Basal Cell Carcinoma in Adult Patients

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Cemiplimab
    Germany

  • Study of Allopurinol to Reduce Cardiovascular Events in High-Risk Patients with Heart Disease and Long-COVID Syndrome

    Recruiting

    3 1 1
    Investigated Diseases:
    • Transient ischaemic attack
    • Atrial fibrillation
    • Ischaemic stroke
    Investigated Drugs:
    • Allopurinol
    Poland

  • Study of Roginolisib for Patients with Advanced Uveal Melanoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Relatlimab
    • Dacarbazine Citrate
    • Ipilimumab
    Italy Spain

  • Study of Pioglitazone and Metformin combination treatment for patients with Metabolic Associated Fatty Liver Disease and prediabetes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glucose tolerance impaired
    • Metabolic dysfunction-associated liver disease
    Investigated Drugs:
    • Pioglitazone
    • Metformin Hydrochloride
    Spain

  • Study on Botulinum Toxin Type A for Treating Hidradenitis Suppurativa in Patients: A Comparison of Different Drug Combinations

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Botulinum Toxin Type A – Haemagglutinin Complex
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    Denmark
Previous Page
1 … 263 264 265 266 267 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!